A new study published in the Journal of the American College of Cardiology reveals that statins, usually prescribed for lowering cholesterol, are also effective in reducing inflammation caused by gum disease with the researchers stating that this could also lead to reduced inflammation in arteries.
"Periodontal disease is characterized by chronic gum inflammation and affects approximately 50 percent of the U.S. adult population," said Ahmed Tawkol, MD, co-director of the Cardiac Imaging Trials Program at Massachusetts General Hospital and Harvard Medical School and co-author of the study. "Periodontitis and atherosclerosis are both primarily driven by inflammation. These inflammatory conditions tend to co-exist within individuals and their biologies may be intertwined."
In the double-blind, randomized study, patients with heart disease or a high heart disease risk were assigned to take either an 80 mg statin or a 10 mg statin daily for 12 weeks. PET/CT scans were collected after four and 12 weeks and compared to scans taken before treatment began. The 59 patients included in the final analysis showed a significant reduction in gum inflammation after as few as four weeks of treatment with the high-dose statin. Interestingly, the improvement in gum inflammation tracked closely with improvement in atherosclerotic disease.
"Statins have beneficial effects beyond their lipid lowering properties," Tawakol said. "Physicians should take this into consideration when discussing antihyperlipidemic treatment options with their patients."
Tawakol added that patients with heart disease and stroke should inform their physicians about any significant gum disease and should be particularly careful to follow existing guidelines for tending to gum disease.